Harvard Bioscience Inc.

NASDAQ: HBIO · Real-Time Price · USD
0.45
-0.22 (-32.86%)
At close: May 30, 2025, 3:59 PM
0.45
-0.44%
After-hours: May 30, 2025, 05:57 PM EDT

Harvard Bioscience Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Instruments, Equipment, Software, and Accessories Revenue 86.96M 105.72M 108.17M 114.11M
Instruments, Equipment, Software, and Accessories Revenue Growth -17.74% -2.26% -5.21% n/a
Service, Maintenance, and Warranty Contracts Revenue 7.17M 6.53M 5.17M 4.79M
Service, Maintenance, and Warranty Contracts Revenue Growth +9.75% +26.38% +7.96% n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Americas, Other Revenue 3.6M 18.49M 16.39M 49.83M 4.63M 4.74M
Americas, Other Revenue Growth -80.55% +12.78% -67.10% +976.96% -2.43% n/a
Asia, Other Revenue 7.1M 48.2M 49.91M n/a n/a n/a
Asia, Other Revenue Growth -85.27% -3.42% n/a n/a n/a n/a
Emea Revenue 28.41M n/a n/a n/a n/a n/a
Emea Revenue Growth n/a n/a n/a n/a n/a n/a
Greater China Revenue 13.3M n/a n/a n/a n/a n/a
Greater China Revenue Growth n/a n/a n/a n/a n/a n/a
United States Revenue 41.74M n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 10.16M 10.2M 10.56M 11.08M 11.87M 11.51M 11.54M 11.53M 12.31M 11.81M 12.14M 12.57M 13.01M 13.46M 11.64M 12.13M 11.72M 11.15M 9.99M 9.95M 12.34M 46.02M 11.9M 10.58M 11.96M 12.55M 10.68M 11.57M 11.03M 10.36M 9.62M 9.39M 10.25M 10.26M 9.81M 10.32M 11.05M 10.3M 10.03M 10.05M 10.03M
Selling, General, and Administrative Revenue Growth -0.41% -3.42% -4.71% -6.62% +3.14% -0.29% +0.07% -6.34% +4.24% -2.73% -3.38% -3.41% -3.31% +15.61% -4.02% +3.50% +5.09% +11.66% +0.38% -19.36% -73.19% +286.82% +12.47% -11.51% -4.76% +17.57% -7.70% +4.87% +6.51% +7.71% +2.44% -8.46% -0.04% +4.61% -5.00% -6.59% +7.32% +2.62% -0.17% +0.20% n/a
Research and Development Revenue 2.32M 2.33M 2.57M 2.63M 2.88M 3.15M 2.76M 2.96M 2.9M 2.85M 2.76M 3.5M 3.22M 2.95M 2.66M 2.7M 2.49M 2.35M 1.95M 1.9M 2.49M 10.71M 2.56M 2.77M 2.73M 3.04M 2.78M 2.76M 2.4M 1.53M 1.54M 1.3M 1.28M 1.16M 1.31M 1.5M 1.43M 1.53M 1.43M 1.71M 1.75M
Research and Development Revenue Growth -0.30% -9.31% -2.25% -8.98% -8.41% +14.13% -6.66% +2.07% +1.68% +3.11% -20.99% +8.60% +9.12% +10.94% -1.52% +8.60% +5.87% +20.52% +2.74% -23.82% -76.76% +317.90% -7.47% +1.32% -10.18% +9.41% +0.91% +14.82% +57.40% -0.78% +18.67% +0.86% +11.16% -11.69% -12.85% +5.40% -6.98% +7.43% -16.80% -1.95% n/a
Sales and Marketing Revenue 4.97M 5.39M 5.52M 5.39M 5.9M 6.22M 5.73M 6.18M 5.98M 5.95M 5.82M 6.59M 6.69M 7.34M 6.18M 5.73M 5.39M 5.47M 4.59M 4.28M 5.58M 23.26M 5.29M 5.77M 6.31M 6.47M 6.02M 6.31M 5.65M 5.92M 5.08M 4.98M 5.05M 5.29M 5.01M 5.09M 5.1M 5.22M 5.03M 5.13M 5.2M
Sales and Marketing Revenue Growth -7.86% -2.23% +2.28% -8.62% -5.08% +8.51% -7.22% +3.35% +0.50% +2.22% -11.66% -1.50% -8.93% +18.76% +7.91% +6.39% -1.54% +19.22% +7.22% -23.30% -76.02% +339.44% -8.25% -8.50% -2.49% +7.41% -4.56% +11.74% -4.71% +16.61% +1.99% -1.31% -4.61% +5.71% -1.57% -0.31% -2.30% +3.86% -1.95% -1.37% n/a